{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T15:30:31Z","timestamp":1790350231068,"version":"4.1.0"},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T00:00:00Z","timestamp":1697673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T00:00:00Z","timestamp":1697673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"NASA Grant","award":["80NSSC20K183"],"award-info":[{"award-number":["80NSSC20K183"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Biomed Eng"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s10439-023-03365-0","type":"journal-article","created":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T11:03:08Z","timestamp":1697713388000},"page":"2708-2721","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Retina Oculomics in Neurodegenerative Disease"],"prefix":"10.1007","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-7241-0994","authenticated-orcid":false,"given":"Alex","family":"Suh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharif Amit","family":"Kamran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan","family":"Waisberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phani","family":"Paladugu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasif","family":"Zaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prithul","family":"Sarker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Tavakkoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew G.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,19]]},"reference":[{"issue":"1","key":"3365_CR1","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nrneurol.2012.227","volume":"9","author":"A London","year":"2013","unstructured":"London, A., I. Benhar, and M. Schwartz. The retina as a window to the brain\u2014from eye research to CNS disorders. Nat. Rev. Neurol. 9(1):44\u201353, 2013. https:\/\/doi.org\/10.1038\/nrneurol.2012.227.","journal-title":"Nat. Rev. Neurol."},{"issue":"2","key":"3365_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1167\/tvst.9.2.6","volume":"9","author":"SK Wagner","year":"2020","unstructured":"Wagner, S. K., D. J. Fu, L. Faes, et al. Insights into systemic disease through retinal imaging-based oculomics. Transl. Vis. Sci. Technol. 9(2):6, 2020. https:\/\/doi.org\/10.1167\/tvst.9.2.6.","journal-title":"Transl. Vis. Sci. Technol."},{"issue":"3","key":"3365_CR3","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3233\/JAD-121975","volume":"34","author":"T Moreno-Ramos","year":"2013","unstructured":"Moreno-Ramos, T., J. Benito-Leon, A. Villarejo, and F. Bermejo-Pareja. Retinal nerve fiber layer thinning in dementia associated with Parkinson\u2019s disease, dementia with Lewy bodies and Alzheimer\u2019s disease. J. Alzheimers Dis. 34(3):659\u2013664, 2013. https:\/\/doi.org\/10.3233\/JAD-121975.","journal-title":"J. Alzheimers Dis."},{"key":"3365_CR4","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3389\/fnagi.2019.00220","volume":"11","author":"T Jo","year":"2019","unstructured":"Jo, T., K. Nho, and A. J. Saykin. Deep learning in Alzheimer\u2019s disease: diagnostic classification and prognostic prediction using neuroimaging data. Front. Aging Neurosci. 11:220, 2019. https:\/\/doi.org\/10.3389\/fnagi.2019.00220.","journal-title":"Front. Aging Neurosci."},{"key":"3365_CR5","doi-asserted-by":"publisher","first-page":"720167","DOI":"10.3389\/fnagi.2021.720167","volume":"13","author":"A Majeed","year":"2021","unstructured":"Majeed, A., B. Marwick, H. Yu, H. Fadavi, and M. Tavakoli. Ophthalmic biomarkers for Alzheimer\u2019s disease: a review. Front. Aging Neurosci. 13:720167, 2021. https:\/\/doi.org\/10.3389\/fnagi.2021.720167.","journal-title":"Front. Aging Neurosci."},{"issue":"8","key":"3365_CR6","doi-asserted-by":"publisher","first-page":"743","DOI":"10.2174\/1567205015666180123122637","volume":"15","author":"K Ukalovic","year":"2018","unstructured":"Ukalovic, K., S. Cao, S. Lee, et al. Drusen in the peripheral retina of the Alzheimer\u2019s eye. Curr. Alzheimer Res. 15(8):743\u2013750, 2018. https:\/\/doi.org\/10.2174\/1567205015666180123122637.","journal-title":"Curr. Alzheimer Res."},{"issue":"6","key":"3365_CR7","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.1177\/11206721211016311","volume":"31","author":"IN Chalkias","year":"2021","unstructured":"Chalkias, I. N., T. Tegos, F. Topouzis, and M. Tsolaki. Ocular biomarkers and their role in the early diagnosis of neurocognitive disorders. Eur. J. Ophthalmol. 31(6):2808\u20132817, 2021. https:\/\/doi.org\/10.1177\/11206721211016311.","journal-title":"Eur. J. Ophthalmol."},{"issue":"5035","key":"3365_CR8","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1126\/science.1957169","volume":"254","author":"D Huang","year":"1991","unstructured":"Huang, D., E. A. Swanson, C. P. Lin, et al. Optical coherence tomography. Science. 254(5035):1178\u20131181, 1991. https:\/\/doi.org\/10.1126\/science.1957169.","journal-title":"Science."},{"issue":"1","key":"3365_CR9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1136\/bjophthalmol-2016-309389","volume":"101","author":"A Koustenis Jr","year":"2017","unstructured":"Koustenis, A., Jr., A. Harris, J. Gross, I. Januleviciene, A. Shah, and B. Siesky. Optical coherence tomography angiography: an overview of the technology and an assessment of applications for clinical research. Br. J. Ophthalmol. 101(1):16\u201320, 2017. https:\/\/doi.org\/10.1136\/bjophthalmol-2016-309389.","journal-title":"Br. J. Ophthalmol."},{"issue":"1040","key":"3365_CR10","doi-asserted-by":"publisher","first-page":"20130832","DOI":"10.1259\/bjr.20130832","volume":"87","author":"TJ Macgillivray","year":"2014","unstructured":"Macgillivray, T. J., E. Trucco, J. R. Cameron, B. Dhillon, J. G. Houston, and E. J. R. Van Beek. Retinal imaging as a source of biomarkers for diagnosis, characterization and prognosis of chronic illness or long-term conditions. Br. J. Radiol. 87(1040):20130832, 2014. https:\/\/doi.org\/10.1259\/bjr.20130832.","journal-title":"Br. J. Radiol."},{"issue":"6","key":"3365_CR11","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1117\/1.1806833","volume":"9","author":"D Schweitzer","year":"2004","unstructured":"Schweitzer, D., M. Hammer, F. Schweitzer, et al. In vivo measurement of time-resolved autofluorescence at the human fundus. J. Biomed. Opt. 9(6):1214\u20131222, 2004. https:\/\/doi.org\/10.1117\/1.1806833.","journal-title":"J. Biomed. Opt."},{"key":"3365_CR12","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.visres.2020.05.003","volume":"174","author":"J Kremers","year":"2020","unstructured":"Kremers, J., D. J. McKeefry, I. J. Murray, and N. R. A. Parry. Developments in non-invasive visual electrophysiology. Vision Res. 174:50\u201356, 2020. https:\/\/doi.org\/10.1016\/j.visres.2020.05.003.","journal-title":"Vision Res."},{"issue":"9","key":"3365_CR13","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S1474-4422(11)70072-2","volume":"10","author":"DE Barnes","year":"2011","unstructured":"Barnes, D. E., and K. Yaffe. The projected effect of risk factor reduction on Alzheimer\u2019s disease prevalence. Lancet Neurol. 10(9):819\u2013828, 2011. https:\/\/doi.org\/10.1016\/S1474-4422(11)70072-2.","journal-title":"Lancet Neurol."},{"key":"3365_CR14","doi-asserted-by":"publisher","first-page":"536","DOI":"10.3389\/fnins.2016.00536","volume":"10","author":"JK Lim","year":"2016","unstructured":"Lim, J. K., Q. X. Li, Z. He, et al. The eye as a biomarker for Alzheimer\u2019s disease. Front Neurosci. 10:536, 2016. https:\/\/doi.org\/10.3389\/fnins.2016.00536.","journal-title":"Front Neurosci."},{"issue":"3","key":"3365_CR15","doi-asserted-by":"publisher","first-page":"965","DOI":"10.3233\/jad-171145","volume":"62","author":"RN Martins","year":"2018","unstructured":"Martins, R. N., V. Villemagne, H. R. Sohrabi, et al. Alzheimer\u2019s disease: a journey from amyloid peptides and oxidative stress, to biomarker technologies and disease prevention strategies\u2014gains from AIBL and DIAN cohort studies. J. Alzheimer Dis. 62(3):965\u2013992, 2018. https:\/\/doi.org\/10.3233\/jad-171145.","journal-title":"J. Alzheimer Dis."},{"issue":"1","key":"3365_CR16","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/01.wad.0000191420.61260.a8","volume":"20","author":"LJ Thal","year":"2006","unstructured":"Thal, L. J., K. Kantarci, E. M. Reiman, et al. The role of biomarkers in clinical trials for Alzheimer disease. Alzheimer Dis. Assoc. Disord. 20(1):6\u201315, 2006. https:\/\/doi.org\/10.1097\/01.wad.0000191420.61260.a8.","journal-title":"Alzheimer Dis. Assoc. Disord."},{"issue":"3","key":"3365_CR17","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","volume":"7","author":"MS Albert","year":"2011","unstructured":"Albert, M. S., S. T. Dekosky, D. Dickson, et al. The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimer Dement. 7(3):270\u2013279, 2011. https:\/\/doi.org\/10.1016\/j.jalz.2011.03.008.","journal-title":"Alzheimer Dement."},{"issue":"4","key":"3365_CR18","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.3233\/JAD-161078","volume":"56","author":"EL Granholm","year":"2017","unstructured":"Granholm, E. L., M. S. Panizzon, J. A. Elman, et al. Pupillary responses as a biomarker of early risk for Alzheimer\u2019s disease. J Alzheimers Dis. 56(4):1419\u20131428, 2017. https:\/\/doi.org\/10.3233\/JAD-161078.","journal-title":"J Alzheimers Dis."},{"key":"3365_CR19","doi-asserted-by":"publisher","first-page":"826503","DOI":"10.1155\/2014\/826503","volume":"2014","author":"T Tian","year":"2014","unstructured":"Tian, T., B. Zhang, Y. Jia, and Z. Li. Promise and challenge: the lens model as a biomarker for early diagnosis of Alzheimer\u2019s disease. Dis. Mark. 2014:826503, 2014. https:\/\/doi.org\/10.1155\/2014\/826503.","journal-title":"Dis. Mark."},{"issue":"4","key":"3365_CR20","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3109\/02713683.2014.930154","volume":"40","author":"N Ornek","year":"2015","unstructured":"Ornek, N., E. Dag, and K. Ornek. Corneal sensitivity and tear function in neurodegenerative diseases. Curr. Eye Res. 40(4):423\u2013428, 2015. https:\/\/doi.org\/10.3109\/02713683.2014.930154.","journal-title":"Curr. Eye Res."},{"key":"3365_CR21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2147\/EB.S391608","volume":"15","author":"P Chaitanuwong","year":"2023","unstructured":"Chaitanuwong, P., S. Jariyakosol, S. Apinyawasisuk, et al. Changes in ocular biomarkers from normal cognitive aging to Alzheimer\u2019s disease: a pilot study. Eye Brain. 15:15\u201323, 2023. https:\/\/doi.org\/10.2147\/EB.S391608.","journal-title":"Eye Brain."},{"issue":"3","key":"3365_CR22","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.3233\/JAD-201521","volume":"83","author":"S Rehan","year":"2021","unstructured":"Rehan, S., N. Giroud, F. Al-Yawer, W. Wittich, and N. Phillips. Visual performance and cortical atrophy in vision-related brain regions differ between older adults with (or at risk for) Alzheimer\u2019s disease. J. Alzheimer Dis. 83(3):1125\u20131148, 2021. https:\/\/doi.org\/10.3233\/JAD-201521.","journal-title":"J. Alzheimer Dis."},{"key":"3365_CR23","doi-asserted-by":"publisher","first-page":"S204","DOI":"10.1016\/j.neuroimage.2010.06.020","volume":"54","author":"M Koronyo-Hamaoui","year":"2011","unstructured":"Koronyo-Hamaoui, M., Y. Koronyo, A. V. Ljubimov, et al. Identification of amyloid plaques in retinas from Alzheimer\u2019s patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model. NeuroImage. 54:S204\u2013S217, 2011. https:\/\/doi.org\/10.1016\/j.neuroimage.2010.06.020.","journal-title":"NeuroImage."},{"issue":"9","key":"3365_CR24","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1093\/oxfordjournals.aje.a010105","volume":"150","author":"CC Klaver","year":"1999","unstructured":"Klaver, C. C., A. Ott, A. Hofman, J. J. Assink, M. M. Breteler, and P. T. de Jong. Is age-related maculopathy associated with Alzheimer\u2019s Disease? The Rotterdam study. Am J Epidemiol. 150(9):963\u2013968, 1999. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a010105.","journal-title":"Am J Epidemiol."},{"issue":"2","key":"3365_CR25","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1001\/archopht.1991.01080020045040","volume":"109","author":"CS Tsai","year":"1991","unstructured":"Tsai, C. S. Optic nerve head and nerve fiber layer in Alzheimer\u2019s disease. Arch. Ophthalmol. 109(2):199, 1991. https:\/\/doi.org\/10.1001\/archopht.1991.01080020045040.","journal-title":"Arch. Ophthalmol."},{"issue":"1","key":"3365_CR26","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.neulet.2010.06.006","volume":"480","author":"Y Lu","year":"2010","unstructured":"Lu, Y., Z. Li, X. Zhang, et al. Retinal nerve fiber layer structure abnormalities in early Alzheimer\u2019s disease: evidence in optical coherence tomography. Neurosci. Lett. 480(1):69\u201372, 2010. https:\/\/doi.org\/10.1016\/j.neulet.2010.06.006.","journal-title":"Neurosci. Lett."},{"issue":"7","key":"3365_CR27","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1007\/s11011-022-00927-4","volume":"37","author":"R Vij","year":"2022","unstructured":"Vij, R., and S. Arora. A systematic survey of advances in retinal imaging modalities for Alzheimer\u2019s disease diagnosis. Metab. Brain Dis. 37(7):2213\u20132243, 2022. https:\/\/doi.org\/10.1007\/s11011-022-00927-4.","journal-title":"Metab. Brain Dis."},{"issue":"10","key":"3365_CR28","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1212\/01.wnl.0000244490.07925.8b","volume":"67","author":"HV Danesh-Meyer","year":"2006","unstructured":"Danesh-Meyer, H. V., H. Birch, J. Y. Ku, S. Carroll, and G. Gamble. Reduction of optic nerve fibers in patients with Alzheimer disease identified by laser imaging. Neurology. 67(10):1852\u20131854, 2006. https:\/\/doi.org\/10.1212\/01.wnl.0000244490.07925.8b.","journal-title":"Neurology."},{"issue":"6","key":"3365_CR29","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1007\/s10792-014-0004-z","volume":"34","author":"SA Kurna","year":"2014","unstructured":"Kurna, S. A., G. Akar, A. Altun, Y. Agirman, E. Gozke, and T. Sengor. Confocal scanning laser tomography of the optic nerve head on the patients with Alzheimer\u2019s disease compared to glaucoma and control. Int. Ophthalmol. 34(6):1203\u20131211, 2014. https:\/\/doi.org\/10.1007\/s10792-014-0004-z.","journal-title":"Int. Ophthalmol."},{"key":"3365_CR30","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.93621","author":"Y Koronyo","year":"2017","unstructured":"Koronyo, Y., D. Biggs, E. Barron, et al. Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer\u2019s disease. JCI Insight. 2017. https:\/\/doi.org\/10.1172\/jci.insight.93621.","journal-title":"JCI Insight."},{"issue":"4","key":"3365_CR31","doi-asserted-by":"publisher","first-page":"e241","DOI":"10.1111\/aos.12609","volume":"93","author":"S Jentsch","year":"2015","unstructured":"Jentsch, S., D. Schweitzer, K. U. Schmidtke, et al. Retinal fluorescence lifetime imaging ophthalmoscopy measures depend on the severity of Alzheimer\u2019s disease. Acta Ophthalmol. 93(4):e241\u2013e247, 2015. https:\/\/doi.org\/10.1111\/aos.12609.","journal-title":"Acta Ophthalmol."},{"issue":"8","key":"3365_CR32","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1038\/s41433-019-0406-2","volume":"33","author":"SR Sadda","year":"2019","unstructured":"Sadda, S. R., E. Borrelli, W. Fan, et al. A pilot study of fluorescence lifetime imaging ophthalmoscopy in preclinical Alzheimer\u2019s disease. Eye (Lond). 33(8):1271\u20131279, 2019. https:\/\/doi.org\/10.1038\/s41433-019-0406-2.","journal-title":"Eye (Lond)."},{"key":"3365_CR33","doi-asserted-by":"publisher","first-page":"8538573","DOI":"10.1155\/2018\/8538573","volume":"2018","author":"P Colligris","year":"2018","unstructured":"Colligris, P., M. J. Perez de Lara, B. Colligris, and J. Pintor. Ocular manifestations of Alzheimer\u2019s and other neurodegenerative diseases: the prospect of the eye as a tool for the early diagnosis of Alzheimer\u2019s disease. J. Ophthalmol. 2018:8538573, 2018. https:\/\/doi.org\/10.1155\/2018\/8538573.","journal-title":"J. Ophthalmol."},{"issue":"6","key":"3365_CR34","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.ophtha.2006.08.046","volume":"114","author":"DL Budenz","year":"2007","unstructured":"Budenz, D. L., D. R. Anderson, R. Varma, et al. Determinants of normal retinal nerve fiber layer thickness measured by stratus OCT. Ophthalmology. 114(6):1046\u20131052, 2007. https:\/\/doi.org\/10.1016\/j.ophtha.2006.08.046.","journal-title":"Ophthalmology."},{"issue":"9","key":"3365_CR35","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1007\/s00417-017-3715-9","volume":"255","author":"JP Cunha","year":"2017","unstructured":"Cunha, J. P., R. Proenca, A. Dias-Santos, et al. OCT in Alzheimer\u2019s disease: thinning of the RNFL and superior hemiretina. Graefes. Arch. Clin. Exp. Ophthalmol. 255(9):1827\u20131835, 2017. https:\/\/doi.org\/10.1007\/s00417-017-3715-9.","journal-title":"Graefes. Arch. Clin. Exp. Ophthalmol."},{"issue":"5","key":"3365_CR36","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1167\/iovs.06-1029","volume":"48","author":"F Berisha","year":"2007","unstructured":"Berisha, F., G. T. Feke, C. L. Trempe, J. W. McMeel, and C. L. Schepens. Retinal abnormalities in early Alzheimer\u2019s disease. Invest. Opthalmol. Vis. Sci. 48(5):2285, 2007. https:\/\/doi.org\/10.1167\/iovs.06-1029.","journal-title":"Invest. Opthalmol. Vis. Sci."},{"key":"3365_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-34577-3","author":"D S\u00e1nchez","year":"2018","unstructured":"S\u00e1nchez, D., M. Castilla-Marti, O. Rodr\u00edguez-G\u00f3mez, et al. Usefulness of peripapillary nerve fiber layer thickness assessed by optical coherence tomography as a biomarker for Alzheimer\u2019s disease. Sci. Rep. 2018. https:\/\/doi.org\/10.1038\/s41598-018-34577-3.","journal-title":"Sci. Rep."},{"key":"3365_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-019-0516-x","author":"J Den Haan","year":"2019","unstructured":"Den Haan, J., L. Csinscik, T. Parker, et al. Retinal thickness as potential biomarker in posterior cortical atrophy and typical Alzheimer\u2019s disease. Alzheimer Res. Ther. 2019. https:\/\/doi.org\/10.1186\/s13195-019-0516-x.","journal-title":"Alzheimer Res. Ther."},{"issue":"4","key":"3365_CR39","doi-asserted-by":"publisher","first-page":"e0214685","DOI":"10.1371\/journal.pone.0214685","volume":"14","author":"YS Zhang","year":"2019","unstructured":"Zhang, Y. S., N. Zhou, B. M. Knoll, et al. Parafoveal vessel loss and correlation between peripapillary vessel density and cognitive performance in amnestic mild cognitive impairment and early Alzheimer\u2019s disease on optical coherence tomography angiography. PLOS ONE. 14(4):e0214685, 2019. https:\/\/doi.org\/10.1371\/journal.pone.0214685.","journal-title":"PLOS ONE."},{"issue":"10","key":"3365_CR40","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.1167\/iovs.19-27028","volume":"60","author":"P Zabel","year":"2019","unstructured":"Zabel, P., J. J. Kaluzny, M. Wilkosc-Debczynska, et al. Comparison of retinal microvasculature in patients with Alzheimer\u2019s disease and primary open-angle glaucoma by optical coherence tomography angiography. Invest. Ophthalmol. Vis. Sci. 60(10):3447\u20133455, 2019. https:\/\/doi.org\/10.1167\/iovs.19-27028.","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"3365_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/jpm10040231","author":"E Salobrar-Garcia","year":"2020","unstructured":"Salobrar-Garcia, E., C. Mendez-Hernandez, R. Hoz, et al. Ocular vascular changes in mild Alzheimer\u2019s disease patients: foveal avascular zone, choroidal thickness, and ONH hemoglobin analysis. J. Pers. Med. 2020. https:\/\/doi.org\/10.3390\/jpm10040231.","journal-title":"J. Pers. Med."},{"issue":"9","key":"3365_CR42","doi-asserted-by":"publisher","first-page":"e0239484","DOI":"10.1371\/journal.pone.0239484","volume":"15","author":"A Lopez-de-Eguileta","year":"2020","unstructured":"Lopez-de-Eguileta, A., C. Lage, S. Lopez-Garcia, et al. Evaluation of choroidal thickness in prodromal Alzheimer\u2019s disease defined by amyloid PET. PLoS One. 15(9):e0239484, 2020. https:\/\/doi.org\/10.1371\/journal.pone.0239484.","journal-title":"PLoS One."},{"issue":"1","key":"3365_CR43","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3233\/JAD-201142","volume":"80","author":"M Li","year":"2021","unstructured":"Li, M., R. Li, J. H. Lyu, et al. Relationship between Alzheimer\u2019s disease and retinal choroidal thickness: a cross-sectional study. J. Alzheimers Dis. 80(1):407\u2013419, 2021. https:\/\/doi.org\/10.3233\/JAD-201142.","journal-title":"J. Alzheimers Dis."},{"key":"3365_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-37271-6","author":"G Querques","year":"2019","unstructured":"Querques, G., E. Borrelli, R. Sacconi, et al. Functional and morphological changes of the retinal vessels in Alzheimer\u2019s disease and mild cognitive impairment. Sci. Rep. 2019. https:\/\/doi.org\/10.1038\/s41598-018-37271-6.","journal-title":"Sci. Rep."},{"issue":"6","key":"3365_CR45","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.oret.2019.02.002","volume":"3","author":"SP Yoon","year":"2019","unstructured":"Yoon, S. P., D. S. Grewal, A. C. Thompson, et al. Retinal microvascular and neurodegenerative changes in Alzheimer\u2019s disease and mild cognitive impairment compared with control participants. Ophthalmol. Retina. 3(6):489\u2013499, 2019. https:\/\/doi.org\/10.1016\/j.oret.2019.02.002.","journal-title":"Ophthalmol. Retina."},{"key":"3365_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/eb.s235238","volume":"13","author":"A Song","year":"2021","unstructured":"Song, A., N. Johnson, A. Ayala, and A. C. Thompson. Optical coherence tomography in patients with Alzheimer\u2019s disease: what can it tell us? Eye Brain. 13:1\u201320, 2021. https:\/\/doi.org\/10.2147\/eb.s235238.","journal-title":"Eye Brain."},{"issue":"2","key":"3365_CR47","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s10633-010-9238-x","volume":"121","author":"K Krasodomska","year":"2010","unstructured":"Krasodomska, K., W. Lubinski, A. Potemkowski, and K. Honczarenko. Pattern electroretinogram (PERG) and pattern visual evoked potential (PVEP) in the early stages of Alzheimer\u2019s disease. Doc. Ophthalmol. 121(2):111\u2013121, 2010. https:\/\/doi.org\/10.1007\/s10633-010-9238-x.","journal-title":"Doc. Ophthalmol."},{"key":"3365_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/biom11081215","author":"C Liao","year":"2021","unstructured":"Liao, C., J. Xu, Y. Chen, and N. Y. Ip. Retinal dysfunction in Alzheimer\u2019s disease and implications for biomarkers. Biomolecules. 2021. https:\/\/doi.org\/10.3390\/biom11081215.","journal-title":"Biomolecules."},{"issue":"2","key":"3365_CR49","doi-asserted-by":"publisher","first-page":"fcad036","DOI":"10.1093\/braincomms\/fcad036","volume":"5","author":"K Samra","year":"2023","unstructured":"Samra, K., A. M. MacDougall, A. Bouzigues, et al. Genetic forms of primary progressive aphasia within the GENetic frontotemporal dementia initiative (GENFI) cohort: comparison with sporadic primary progressive aphasia. Brain Commun. 5(2):fcad036, 2023. https:\/\/doi.org\/10.1093\/braincomms\/fcad036.","journal-title":"Brain Commun."},{"issue":"7","key":"3365_CR50","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/nrneurol.2017.75","volume":"13","author":"LH Meeter","year":"2017","unstructured":"Meeter, L. H., L. D. Kaat, J. D. Rohrer, and J. C. Van Swieten. Imaging and fluid biomarkers in frontotemporal dementia. Nat. Rev. Neurol. 13(7):406\u2013419, 2017. https:\/\/doi.org\/10.1038\/nrneurol.2017.75.","journal-title":"Nat. Rev. Neurol."},{"issue":"4","key":"3365_CR51","doi-asserted-by":"publisher","first-page":"e516","DOI":"10.1212\/CPJ.0000000000001041","volume":"11","author":"O Moinuddin","year":"2021","unstructured":"Moinuddin, O., N. S. Khandwala, K. Z. Young, et al. Role of optical coherence tomography in identifying retinal biomarkers in frontotemporal dementia: a review. Neurol. Clin. Pract. 11(4):e516\u2013e523, 2021. https:\/\/doi.org\/10.1212\/CPJ.0000000000001041.","journal-title":"Neurol. Clin. Pract."},{"key":"3365_CR52","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.cortex.2018.02.011","volume":"103","author":"R Hutchings","year":"2018","unstructured":"Hutchings, R., R. Palermo, J. Bruggemann, J. R. Hodges, O. Piguet, and F. Kumfor. Looking but not seeing: increased eye fixations in behavioural-variant frontotemporal dementia. Cortex. 103:71\u201381, 2018. https:\/\/doi.org\/10.1016\/j.cortex.2018.02.011.","journal-title":"Cortex."},{"issue":"9","key":"3365_CR53","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1007\/s00415-008-0890-y","volume":"255","author":"SY Moon","year":"2008","unstructured":"Moon, S. Y., B. H. Lee, S. W. Seo, S. J. Kang, and D. L. Na. Slow vertical saccades in the frontotemporal dementia with motor neuron disease. J. Neurol. 255(9):1337\u20131343, 2008. https:\/\/doi.org\/10.1007\/s00415-008-0890-y.","journal-title":"J. Neurol."},{"issue":"3","key":"3365_CR54","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.3233\/JAD-160886","volume":"56","author":"L Ferrari","year":"2017","unstructured":"Ferrari, L., S. C. Huang, G. Magnani, A. Ambrosi, G. Comi, and L. Leocani. Optical coherence tomography reveals retinal neuroaxonal thinning in frontotemporal dementia as in Alzheimer\u2019s disease. J. Alzheimers Dis. 56(3):1101\u20131107, 2017. https:\/\/doi.org\/10.3233\/JAD-160886.","journal-title":"J. Alzheimers Dis."},{"issue":"15","key":"3365_CR55","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1212\/wnl.0000000000004500","volume":"89","author":"BJ Kim","year":"2017","unstructured":"Kim, B. J., D. J. Irwin, D. Song, et al. Optical coherence tomography identifies outer retina thinning in frontotemporal degeneration. Neurology. 89(15):1604\u20131611, 2017. https:\/\/doi.org\/10.1212\/wnl.0000000000004500.","journal-title":"Neurology."},{"key":"3365_CR56","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3389\/fnins.2019.00298","volume":"13","author":"BJ Kim","year":"2019","unstructured":"Kim, B. J., M. Grossman, D. Song, et al. Persistent and progressive outer retina thinning in frontotemporal degeneration. Front. Neurosci. 13:298, 2019. https:\/\/doi.org\/10.3389\/fnins.2019.00298.","journal-title":"Front. Neurosci."},{"issue":"2","key":"3365_CR57","doi-asserted-by":"publisher","first-page":"181","DOI":"10.31053\/1853.0605.v79.n2.33610","volume":"79","author":"P Cofreces","year":"2022","unstructured":"Cofreces, P., S. D. Ofman, J. A. Estay, and P. D. Hermida. Enfermedad de Parkinson: una actualizacion bibliografica de los aspectos psicosociales. Rev. Fac. Cien. Med. Univ. Nac. Cordoba. 79(2):181\u2013187, 2022. https:\/\/doi.org\/10.31053\/1853.0605.v79.n2.33610.","journal-title":"Rev. Fac. Cien. Med. Univ. Nac. Cordoba."},{"issue":"3","key":"3365_CR58","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s11011-023-01180-z","volume":"38","author":"MA Khan","year":"2023","unstructured":"Khan, M. A., N. Haider, T. Singh, et al. Promising biomarkers and therapeutic targets for the management of Parkinson\u2019s disease: recent advancements and contemporary research. Metab Brain Dis. 38(3):873\u2013919, 2023. https:\/\/doi.org\/10.1007\/s11011-023-01180-z.","journal-title":"Metab Brain Dis."},{"issue":"4","key":"3365_CR59","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s00702-023-02614-9","volume":"130","author":"A Rekik","year":"2023","unstructured":"Rekik, A., S. Mrabet, A. Nasri, et al. Eye movement study in essential tremor patients and its clinical correlates. J. Neural. Transm. (Vienna). 130(4):537\u2013548, 2023. https:\/\/doi.org\/10.1007\/s00702-023-02614-9.","journal-title":"J. Neural. Transm. (Vienna)."},{"issue":"10","key":"3365_CR60","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/j.visres.2004.11.006","volume":"45","author":"S Davidsdottir","year":"2005","unstructured":"Davidsdottir, S., A. Cronin-Golomb, and A. Lee. Visual and spatial symptoms in Parkinson\u2019s disease. Vision Res. 45(10):1285\u20131296, 2005. https:\/\/doi.org\/10.1016\/j.visres.2004.11.006.","journal-title":"Vision Res."},{"key":"3365_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/4163239","volume":"2018","author":"J Huang","year":"2018","unstructured":"Huang, J., Y. Li, J. Xiao, et al. Combination of multifocal electroretinogram and spectral-domain OCT can increase diagnostic efficacy of Parkinson\u2019s disease. Parkinson\u2019s Dis. 2018:1\u20137, 2018. https:\/\/doi.org\/10.1155\/2018\/4163239.","journal-title":"Parkinson's Dis."},{"issue":"3","key":"3365_CR62","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s10072-018-3244-2","volume":"39","author":"M Unlu","year":"2018","unstructured":"Unlu, M., D. Gulmez Sevim, M. Gultekin, and C. Karaca. Correlations among multifocal electroretinography and optical coherence tomography findings in patients with Parkinson\u2019s disease. Neurol. Sci. 39(3):533\u2013541, 2018. https:\/\/doi.org\/10.1007\/s10072-018-3244-2.","journal-title":"Neurol. Sci."},{"issue":"8","key":"3365_CR63","doi-asserted-by":"publisher","first-page":"e672","DOI":"10.1111\/aos.12764","volume":"93","author":"B Stemplewitz","year":"2015","unstructured":"Stemplewitz, B., M. Keseru, D. Bittersohl, et al. Scanning laser polarimetry and spectral domain optical coherence tomography for the detection of retinal changes in Parkinson\u2019s disease. Acta Ophthalmol. 93(8):e672\u2013e677, 2015. https:\/\/doi.org\/10.1111\/aos.12764.","journal-title":"Acta Ophthalmol."},{"issue":"1\u20132","key":"3365_CR64","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jns.2015.05.007","volume":"355","author":"J Chorostecki","year":"2015","unstructured":"Chorostecki, J., N. Seraji-Bozorgzad, A. Shah, et al. Characterization of retinal architecture in Parkinson\u2019s disease. J. Neurol. Sci. 355(1\u20132):44\u201348, 2015. https:\/\/doi.org\/10.1016\/j.jns.2015.05.007.","journal-title":"J. Neurol. Sci."},{"issue":"7","key":"3365_CR65","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1212\/01.wnl.0000178896.44905.33","volume":"65","author":"D Devos","year":"2005","unstructured":"Devos, D., M. Tir, C. A. Maurage, et al. ERG and anatomical abnormalities suggesting retinopathy in dementia with Lewy bodies. Neurology. 65(7):1107\u20131110, 2005. https:\/\/doi.org\/10.1212\/01.wnl.0000178896.44905.33.","journal-title":"Neurology."},{"key":"3365_CR66","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2022-329342","author":"JN Alves","year":"2023","unstructured":"Alves, J. N., B. U. Westner, A. H\u00f8jlund, R. S. Weil, and S. S. Dalal. Structural and functional changes in the retina in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 2023. https:\/\/doi.org\/10.1136\/jnnp-2022-329342.","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"3","key":"3365_CR67","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/WNO.0000000000000240","volume":"35","author":"M Kaur","year":"2015","unstructured":"Kaur, M., R. Saxena, D. Singh, M. Behari, P. Sharma, and V. Menon. Correlation between structural and functional retinal changes in Parkinson disease. J Neuroophthalmol. 35(3):254\u2013258, 2015. https:\/\/doi.org\/10.1097\/WNO.0000000000000240.","journal-title":"J Neuroophthalmol."},{"issue":"2","key":"3365_CR68","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/WNO.0000000000000203","volume":"35","author":"ES Sari","year":"2015","unstructured":"Sari, E. S., R. Koc, A. Yazici, G. Sahin, and S. S. Ermis. Ganglion cell-inner plexiform layer thickness in patients with Parkinson disease and association with disease severity and duration. J Neuroophthalmol. 35(2):117\u2013121, 2015. https:\/\/doi.org\/10.1097\/WNO.0000000000000203.","journal-title":"J Neuroophthalmol."},{"issue":"1","key":"3365_CR69","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1080\/02713683.2017.1370116","volume":"43","author":"M Satue","year":"2018","unstructured":"Satue, M., J. Obis, R. Alarcia, et al. Retinal and choroidal changes in patients with Parkinson\u2019s disease detected by swept-source optical coherence tomography. Curr. Eye Res. 43(1):109\u2013115, 2018. https:\/\/doi.org\/10.1080\/02713683.2017.1370116.","journal-title":"Curr. Eye Res."},{"issue":"5","key":"3365_CR70","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.oftal.2018.01.004","volume":"93","author":"J Obis","year":"2018","unstructured":"Obis, J., M. Satue, R. Alarcia, L. E. Pablo, and E. Garcia-Martin. Actualizacion sobre alteraciones de funcion visual y espesores coriorretinianos en la enfermedad de Parkinson. Arch. Soc. Esp. Oftalmol. (Engl Ed). 93(5):231\u2013238, 2018. https:\/\/doi.org\/10.1016\/j.oftal.2018.01.004.","journal-title":"Arch. Soc. Esp. Oftalmol. (Engl Ed)."},{"issue":"4","key":"3365_CR71","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.3233\/JPD-212676","volume":"11","author":"GL Brown","year":"2021","unstructured":"Brown, G. L., M. L. Camacci, S. D. Kim, et al. Choroidal thickness correlates with clinical and imaging metrics of Parkinson\u2019s disease: a pilot study. J. Parkinsons Dis. 11(4):1857\u20131868, 2021. https:\/\/doi.org\/10.3233\/JPD-212676.","journal-title":"J. Parkinsons Dis."},{"issue":"4","key":"3365_CR72","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1080\/08820538.2017.1307423","volume":"33","author":"MM Moschos","year":"2018","unstructured":"Moschos, M. M., and I. P. Chatziralli. Evaluation of choroidal and retinal thickness changes in Parkinson\u2019s disease using spectral domain optical coherence tomography. Semin. Ophthalmol. 33(4):494\u2013497, 2018. https:\/\/doi.org\/10.1080\/08820538.2017.1307423.","journal-title":"Semin. Ophthalmol."},{"issue":"1","key":"3365_CR73","doi-asserted-by":"publisher","first-page":"e68","DOI":"10.1111\/aos.12809","volume":"94","author":"M Eraslan","year":"2016","unstructured":"Eraslan, M., E. Cerman, S. Yildiz Balci, et al. The choroid and lamina cribrosa is affected in patients with Parkinson\u2019s disease: enhanced depth imaging optical coherence tomography study. Acta Ophthalmol. 94(1):e68-75, 2016. https:\/\/doi.org\/10.1111\/aos.12809.","journal-title":"Acta Ophthalmol."},{"issue":"5","key":"3365_CR74","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1007\/s10792-021-02133-0","volume":"42","author":"Y Kamata","year":"2022","unstructured":"Kamata, Y., N. Hara, T. Satou, T. Niida, and K. Mukuno. Investigation of the pathophysiology of the retina and choroid in Parkinson\u2019s disease by optical coherence tomography. Int. Ophthalmol. 42(5):1437\u20131445, 2022. https:\/\/doi.org\/10.1007\/s10792-021-02133-0.","journal-title":"Int. Ophthalmol."},{"issue":"1","key":"3365_CR75","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13195-022-01054-z","volume":"14","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y., L. Yang, Y. Gao, et al. Choroid and choriocapillaris changes in early-stage Parkinson\u2019s disease: a swept-source optical coherence tomography angiography-based cross-sectional study. Alzheimers Res. Ther. 14(1):116, 2022. https:\/\/doi.org\/10.1186\/s13195-022-01054-z.","journal-title":"Alzheimers Res. Ther."},{"issue":"5","key":"3365_CR76","doi-asserted-by":"publisher","first-page":"e0177163","DOI":"10.1371\/journal.pone.0177163","volume":"12","author":"E Garcia-Martin","year":"2017","unstructured":"Garcia-Martin, E., L. E. Pablo, M. P. Bambo, et al. Comparison of peripapillary choroidal thickness between healthy subjects and patients with Parkinson\u2019s disease. PLoS One. 12(5):e0177163, 2017. https:\/\/doi.org\/10.1371\/journal.pone.0177163.","journal-title":"PLoS One."},{"issue":"2","key":"3365_CR77","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1167\/iovs.13-13062","volume":"55","author":"E Garcia-Martin","year":"2014","unstructured":"Garcia-Martin, E., D. Rodriguez-Mena, M. Satue, et al. Electrophysiology and optical coherence tomography to evaluate Parkinson disease severity. Invest. Ophthalmol. Vis. Sci. 55(2):696\u2013705, 2014. https:\/\/doi.org\/10.1167\/iovs.13-13062.","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"3365_CR78","doi-asserted-by":"publisher","first-page":"24","DOI":"10.5301\/ejo.2010.1318","volume":"21","author":"MM Moschos","year":"2011","unstructured":"Moschos, M. M., G. Tagaris, I. Markopoulos, et al. Morphologic changes and functional retinal impairment in patients with Parkinson disease without visual loss. Eur. J. Ophthalmol. 21(1):24\u201329, 2011. https:\/\/doi.org\/10.5301\/ejo.2010.1318.","journal-title":"Eur. J. Ophthalmol."},{"issue":"5","key":"3365_CR79","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1001\/archneur.1982.00510170026007","volume":"39","author":"MJ Kupersmith","year":"1982","unstructured":"Kupersmith, M. J., E. Shakin, I. M. Siegel, and A. Lieberman. Visual system abnormalities in patients with Parkinson\u2019s disease. Arch. Neurol. 39(5):284\u2013286, 1982. https:\/\/doi.org\/10.1001\/archneur.1982.00510170026007.","journal-title":"Arch. Neurol."},{"issue":"2","key":"3365_CR80","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10633-022-09887-7","volume":"145","author":"M Batum","year":"2022","unstructured":"Batum, M., A. K. Ak, M. S. Ari, H. Mayali, E. Kurt, and D. Selcuki. Evaluation of the visual system with visual evoked potential and optical coherence tomography in patients with idiopathic Parkinson\u2019s disease and with multiple system atrophy. Doc. Ophthalmol. 145(2):99\u2013112, 2022. https:\/\/doi.org\/10.1007\/s10633-022-09887-7.","journal-title":"Doc. Ophthalmol."},{"issue":"5","key":"3365_CR81","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.neucli.2021.02.003","volume":"51","author":"C Carrarini","year":"2021","unstructured":"Carrarini, C., M. Russo, G. Pagliaccio, et al. Visual evoked potential abnormalities in dementia with Lewy bodies. Neurophysiol. Clin. 51(5):425\u2013431, 2021. https:\/\/doi.org\/10.1016\/j.neucli.2021.02.003.","journal-title":"Neurophysiol. Clin."},{"key":"3365_CR82","doi-asserted-by":"publisher","first-page":"718820","DOI":"10.3389\/fnins.2021.718820","volume":"15","author":"M Zhou","year":"2021","unstructured":"Zhou, M., L. Wu, Q. Hu, et al. Visual impairments are associated with retinal microvascular density in patients with Parkinson\u2019s disease. Front. Neurosci. 15:718820, 2021. https:\/\/doi.org\/10.3389\/fnins.2021.718820.","journal-title":"Front. Neurosci."},{"key":"3365_CR83","doi-asserted-by":"publisher","first-page":"7739944","DOI":"10.1155\/2023\/7739944","volume":"2023","author":"Z Tuncer","year":"2023","unstructured":"Tuncer, Z., G. Dereli Can, H. Donmez Keklikoglu, F. A. Eren, F. Yulek, and O. Deniz. The Relationship between visual-evoked potential and optic coherence tomography and clinical findings in Parkinson patients. Parkinsons Dis. 2023:7739944, 2023. https:\/\/doi.org\/10.1155\/2023\/7739944.","journal-title":"Parkinsons Dis."},{"issue":"1","key":"3365_CR84","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1023\/b:doop.0000019487.88486.0a","volume":"108","author":"P Witkovsky","year":"2004","unstructured":"Witkovsky, P. Dopamine and retinal function. Doc. Ophthalmol. 108(1):17\u201339, 2004. https:\/\/doi.org\/10.1023\/b:doop.0000019487.88486.0a.","journal-title":"Doc. Ophthalmol."},{"issue":"19","key":"3365_CR85","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1016\/0042-6989(94)90248-8","volume":"34","author":"H Ikeda","year":"1994","unstructured":"Ikeda, H., G. M. Head, and C. J. Ellis. Electrophysiological signs of retinal dopamine deficiency in recently diagnosed Parkinson\u2019s disease and a follow up study. Vision Res. 34(19):2629\u20132638, 1994. https:\/\/doi.org\/10.1016\/0042-6989(94)90248-8.","journal-title":"Vision Res."},{"issue":"5","key":"3365_CR86","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/BF02172892","volume":"227","author":"I Gottlob","year":"1989","unstructured":"Gottlob, I., H. Weghaupt, C. Vass, and E. Auff. Effect of levodopa on the human pattern electroretinogram and pattern visual evoked potentials. Graefes. Arch. Clin. Exp. Ophthalmol. 227(5):421\u2013427, 1989. https:\/\/doi.org\/10.1007\/BF02172892.","journal-title":"Graefes. Arch. Clin. Exp. Ophthalmol."},{"key":"3365_CR87","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-023-02653-x","author":"EE Christou","year":"2023","unstructured":"Christou, E. E., S. Konitsiotis, K. Pamporis, et al. Inner retinal layers\u2019 alterations of the microvasculature in early stages of Parkinson\u2019s disease: a cross sectional study. Int. Ophthalmol. 2023. https:\/\/doi.org\/10.1007\/s10792-023-02653-x.","journal-title":"Int. Ophthalmol."},{"issue":"3","key":"3365_CR88","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/08820538.2021.1987482","volume":"37","author":"EE Christou","year":"2022","unstructured":"Christou, E. E., I. Asproudis, C. Asproudis, A. Giannakis, M. Stefaniotou, and S. Konitsiotis. Macular microcirculation characteristics in Parkinson\u2019s disease evaluated by OCT-angiography: a literature review. Semin. Ophthalmol. 37(3):399\u2013407, 2022. https:\/\/doi.org\/10.1080\/08820538.2021.1987482.","journal-title":"Semin. Ophthalmol."},{"issue":"10","key":"3365_CR89","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.1167\/iovs.17-23230","volume":"59","author":"WR Kwapong","year":"2018","unstructured":"Kwapong, W. R., H. Ye, C. Peng, et al. Retinal microvascular impairment in the early stages of Parkinson\u2019s disease. Invest. Ophthalmol. Vis. Sci. 59(10):4115\u20134122, 2018. https:\/\/doi.org\/10.1167\/iovs.17-23230.","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"3365_CR90","doi-asserted-by":"publisher","DOI":"10.3390\/cells12071031","author":"MS McGrath","year":"2023","unstructured":"McGrath, M. S., R. Zhang, P. M. Bracci, A. Azhir, and B. D. Forrest. Regulation of the innate immune system as a therapeutic approach to supporting respiratory function in ALS. Cells. 2023. https:\/\/doi.org\/10.3390\/cells12071031.","journal-title":"Cells."},{"issue":"5","key":"3365_CR91","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1097\/wco.0000000000000854","volume":"33","author":"N Verber","year":"2020","unstructured":"Verber, N., and P. J. Shaw. Biomarkers in amyotrophic lateral sclerosis: a review of new developments. Curr. Opin. Neurol. 33(5):662\u2013668, 2020. https:\/\/doi.org\/10.1097\/wco.0000000000000854.","journal-title":"Curr. Opin. Neurol."},{"issue":"12","key":"3365_CR92","doi-asserted-by":"publisher","first-page":"729","DOI":"10.5692\/clinicalneurol.cn-001220","volume":"58","author":"H Mitsumoto","year":"2018","unstructured":"Mitsumoto, H., and T. Saito. A prognostic biomarker in amyotrophic lateral sclerosis. Rinsho Shinkeigaku. 58(12):729\u2013736, 2018. https:\/\/doi.org\/10.5692\/clinicalneurol.cn-001220.","journal-title":"Rinsho Shinkeigaku."},{"key":"3365_CR93","doi-asserted-by":"publisher","DOI":"10.3233\/JND-221579","author":"CE Youn","year":"2023","unstructured":"Youn, C. E., C. Lu, J. Cauchi, D. MacGowan, R. Morgenstern, and S. Scelsa. Oculomotor dysfunction in motor neuron disease. J. Neuromuscul. Dis. 2023. https:\/\/doi.org\/10.3233\/JND-221579.","journal-title":"J. Neuromuscul. Dis."},{"issue":"4","key":"3365_CR94","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/acn3.46","volume":"1","author":"M Ringelstein","year":"2014","unstructured":"Ringelstein, M., P. Albrecht, M. S\u00fcdmeyer, et al. Subtle retinal pathology in amyotrophic lateral sclerosis. Ann. Clin. Transl. Neurol. 1(4):290\u2013297, 2014. https:\/\/doi.org\/10.1002\/acn3.46.","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"2","key":"3365_CR95","doi-asserted-by":"publisher","first-page":"369","DOI":"10.4103\/ijo.IJO_1870_22","volume":"71","author":"B Mohanty","year":"2023","unstructured":"Mohanty, B., A. K. Misra, S. Kumar, et al. Retinal nerve fiber layer thinning found in amyotrophic lateral sclerosis\u2014Correlation with disease duration and severity. Indian J. Ophthalmol. 71(2):369\u2013378, 2023. https:\/\/doi.org\/10.4103\/ijo.IJO_1870_22.","journal-title":"Indian J. Ophthalmol."},{"key":"3365_CR96","doi-asserted-by":"publisher","first-page":"783431","DOI":"10.3389\/fnagi.2021.783431","volume":"13","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y., X. Liu, J. Fu, et al. Selective and inverse U-shaped curve alteration of the retinal nerve in amyotrophic lateral sclerosis: a potential mirror of the disease. Front. Aging Neurosci. 13:783431, 2021. https:\/\/doi.org\/10.3389\/fnagi.2021.783431.","journal-title":"Front. Aging Neurosci."},{"issue":"3","key":"3365_CR97","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00702-015-1483-4","volume":"123","author":"A Hubers","year":"2016","unstructured":"Hubers, A., H. P. Muller, J. Dreyhaupt, et al. Retinal involvement in amyotrophic lateral sclerosis: a study with optical coherence tomography and diffusion tensor imaging. J. Neural. Transm. (Vienna). 123(3):281\u2013287, 2016. https:\/\/doi.org\/10.1007\/s00702-015-1483-4.","journal-title":"J. Neural. Transm. (Vienna)."},{"issue":"7","key":"3365_CR98","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1007\/s00415-018-8863-2","volume":"265","author":"M Rohani","year":"2018","unstructured":"Rohani, M., A. Meysamie, B. Zamani, M. M. Sowlat, and F. H. Akhoundi. Reduced retinal nerve fiber layer (RNFL) thickness in ALS patients: a window to disease progression. J. Neurol. 265(7):1557\u20131562, 2018. https:\/\/doi.org\/10.1007\/s00415-018-8863-2.","journal-title":"J. Neurol."},{"issue":"9","key":"3365_CR99","doi-asserted-by":"publisher","first-page":"e2741","DOI":"10.1002\/brb3.2741","volume":"12","author":"G Nepal","year":"2022","unstructured":"Nepal, G., S. Kharel, M. A. Coghlan, et al. Amyotrophic lateral sclerosis and retinal changes in optical coherence tomography: a systematic review and meta-analysis. Brain Behav. 12(9):e2741, 2022. https:\/\/doi.org\/10.1002\/brb3.2741.","journal-title":"Brain Behav."},{"key":"3365_CR100","doi-asserted-by":"publisher","first-page":"204062231988220","DOI":"10.1177\/2040622319882205","volume":"10","author":"TE Yap","year":"2019","unstructured":"Yap, T. E., S. I. Balendra, M. T. Almonte, and M. F. Cordeiro. Retinal correlates of neurological disorders. Ther. Adv. Chronic Dis. 10:2040622319882205, 2019. https:\/\/doi.org\/10.1177\/2040622319882205.","journal-title":"Ther. Adv. Chronic Dis."},{"issue":"4","key":"3365_CR101","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s00415-018-8787-x","volume":"265","author":"A Abdelhak","year":"2018","unstructured":"Abdelhak, A., A. H\u00fcbers, K. B\u00f6hm, A. C. Ludolph, J. Kassubek, and E. H. Pinkhardt. In vivo assessment of retinal vessel pathology in amyotrophic lateral sclerosis. J. Neurol. 265(4):949\u2013953, 2018. https:\/\/doi.org\/10.1007\/s00415-018-8787-x.","journal-title":"J. Neurol."},{"issue":"9010","key":"3365_CR102","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/s0140-6736(96)90737-0","volume":"347","author":"G Kolde","year":"1996","unstructured":"Kolde, G., R. Bachus, and A. C. Ludolph. Skin involvement in amyotrophic lateral sclerosis. Lancet. 347(9010):1226\u20131227, 1996. https:\/\/doi.org\/10.1016\/s0140-6736(96)90737-0.","journal-title":"Lancet."},{"key":"3365_CR103","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10102390","author":"G Cennamo","year":"2022","unstructured":"Cennamo, G., D. Montorio, F. P. Ausiello, et al. Correlation between retinal vascularization and disease aggressiveness in amyotrophic lateral sclerosis. Biomedicines. 2022. https:\/\/doi.org\/10.3390\/biomedicines10102390.","journal-title":"Biomedicines."},{"issue":"1","key":"3365_CR104","doi-asserted-by":"publisher","first-page":"29187","DOI":"10.1038\/srep29187","volume":"6","author":"JM Simonett","year":"2016","unstructured":"Simonett, J. M., R. Huang, N. Siddique, et al. Macular sub-layer thinning and association with pulmonary function tests in Amyotrophic Lateral Sclerosis. Sci. Rep. 6(1):29187, 2016. https:\/\/doi.org\/10.1038\/srep29187.","journal-title":"Sci. Rep."},{"issue":"2","key":"3365_CR105","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1042\/BJ20071619","volume":"412","author":"S Imarisio","year":"2008","unstructured":"Imarisio, S., J. Carmichael, V. Korolchuk, et al. Huntington\u2019s disease: from pathology and genetics to potential therapies. Biochem. J. 412(2):191\u2013209, 2008. https:\/\/doi.org\/10.1042\/BJ20071619.","journal-title":"Biochem. J."},{"key":"3365_CR106","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.mcn.2019.02.004","volume":"97","author":"P Zeun","year":"2019","unstructured":"Zeun, P., R. I. Scahill, S. J. Tabrizi, and E. J. Wild. Fluid and imaging biomarkers for Huntington\u2019s disease. Mol. Cell Neurosci. 97:67\u201380, 2019. https:\/\/doi.org\/10.1016\/j.mcn.2019.02.004.","journal-title":"Mol. Cell Neurosci."},{"issue":"3","key":"3365_CR107","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s10633-018-9632-3","volume":"136","author":"J Knapp","year":"2018","unstructured":"Knapp, J., D. A. VanNasdale, K. Ramsey, and J. Racine. Retinal dysfunction in a presymptomatic patient with Huntington\u2019s disease. Doc. Ophthalmol. 136(3):213\u2013221, 2018. https:\/\/doi.org\/10.1007\/s10633-018-9632-3.","journal-title":"Doc. Ophthalmol."},{"issue":"10","key":"3365_CR108","doi-asserted-by":"publisher","first-page":"5933","DOI":"10.1007\/s10072-022-06232-3","volume":"43","author":"E Amini","year":"2022","unstructured":"Amini, E., M. Moghaddasi, S. A. H. Habibi, et al. Huntington\u2019s disease and neurovascular structure of retina. Neurol. Sci. 43(10):5933\u20135941, 2022. https:\/\/doi.org\/10.1007\/s10072-022-06232-3.","journal-title":"Neurol. Sci."},{"issue":"12","key":"3365_CR109","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1080\/00207454.2018.1489807","volume":"128","author":"E Gatto","year":"2018","unstructured":"Gatto, E., V. Parisi, G. Persi, et al. Optical coherence tomography (OCT) study in Argentinean Huntington\u2019s disease patients. Int. J. Neurosci. 128(12):1157\u20131162, 2018. https:\/\/doi.org\/10.1080\/00207454.2018.1489807.","journal-title":"Int. J. Neurosci."},{"key":"3365_CR110","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-023-11720-3","author":"A Murueta-Goyena","year":"2023","unstructured":"Murueta-Goyena, A., R. Del Pino, M. Acera, et al. Retinal thickness as a biomarker of cognitive impairment in manifest Huntington\u2019s disease. J. Neurol. 2023. https:\/\/doi.org\/10.1007\/s00415-023-11720-3.","journal-title":"J. Neurol."},{"issue":"11","key":"3365_CR111","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1007\/s00415-015-7869-2","volume":"262","author":"HM Kersten","year":"2015","unstructured":"Kersten, H. M., H. V. Danesh-Meyer, D. H. Kilfoyle, and R. H. Roxburgh. Optical coherence tomography findings in Huntington\u2019s disease: a potential biomarker of disease progression. J. Neurol. 262(11):2457\u20132465, 2015. https:\/\/doi.org\/10.1007\/s00415-015-7869-2.","journal-title":"J. Neurol."},{"issue":"6","key":"3365_CR112","doi-asserted-by":"publisher","first-page":"e2592","DOI":"10.1002\/brb3.2592","volume":"12","author":"RD Schmid","year":"2022","unstructured":"Schmid, R. D., J. Remlinger, M. Abegg, et al. No optical coherence tomography changes in premanifest Huntington\u2019s disease mutation carriers far from disease onset. Brain Behav. 12(6):e2592, 2022. https:\/\/doi.org\/10.1002\/brb3.2592.","journal-title":"Brain Behav."},{"issue":"3","key":"3365_CR113","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/mds.26486","volume":"31","author":"C Andrade","year":"2016","unstructured":"Andrade, C., J. Beato, A. Monteiro, et al. Spectral-domain optical coherence tomography as a potential biomarker in Huntington\u2019s disease. Mov. Disord. 31(3):377\u2013383, 2016. https:\/\/doi.org\/10.1002\/mds.26486.","journal-title":"Mov. Disord."},{"issue":"2","key":"3365_CR114","doi-asserted-by":"publisher","first-page":"e0282175","DOI":"10.1371\/journal.pone.0282175","volume":"18","author":"P Dusek","year":"2023","unstructured":"Dusek, P., A. Kopal, M. Brichova, et al. Is retina affected in Huntington\u2019s disease? Is optical coherence tomography a good biomarker? PLoS One. 18(2):e0282175, 2023. https:\/\/doi.org\/10.1371\/journal.pone.0282175.","journal-title":"PLoS One."},{"issue":"3","key":"3365_CR115","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/s10072-020-04611-2","volume":"42","author":"LG Di Maio","year":"2021","unstructured":"Di Maio, L. G., D. Montorio, S. Peluso, et al. Optical coherence tomography angiography findings in Huntington\u2019s disease. Neurol. Sci. 42(3):995\u20131001, 2021. https:\/\/doi.org\/10.1007\/s10072-020-04611-2.","journal-title":"Neurol. Sci."},{"key":"3365_CR116","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23105450","author":"I Mazur-Michalek","year":"2022","unstructured":"Mazur-Michalek, I., K. Kowalska, D. Zielonka, et al. Structural abnormalities of the optic nerve and retina in huntington\u2019s disease pre-clinical and clinical settings. Int. J. Mol. Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23105450.","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"3365_CR117","doi-asserted-by":"publisher","first-page":"e56026","DOI":"10.1371\/journal.pone.0056026","volume":"8","author":"M Li","year":"2013","unstructured":"Li, M., D. Yasumura, A. A. K. Ma, et al. Intravitreal administration of HA-1077, a ROCK inhibitor, improves retinal function in a mouse model of Huntington disease. PLoS ONE. 8(2):e56026, 2013. https:\/\/doi.org\/10.1371\/journal.pone.0056026.","journal-title":"PLoS ONE."},{"issue":"26","key":"3365_CR118","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1093\/hmg\/11.26.3351","volume":"11","author":"D Helmlinger","year":"2002","unstructured":"Helmlinger, D., G. Yvert, S. Picaud, et al. Progressive retinal degeneration and dysfunction in R6 Huntington\u2019s disease mice. Hum. Mol. Genet. 11(26):3351\u20133359, 2002. https:\/\/doi.org\/10.1093\/hmg\/11.26.3351.","journal-title":"Hum. Mol. Genet."},{"issue":"6","key":"3365_CR119","doi-asserted-by":"publisher","first-page":"548","DOI":"10.3341\/kjo.2016.0118","volume":"31","author":"JY Kwon","year":"2017","unstructured":"Kwon, J. Y., J. H. Yang, J. S. Han, and D. G. Kim. Analysis of the retinal nerve fiber layer thickness in Alzheimer disease and mild cognitive impairment. Korean J. Ophthalmol. 31(6):548\u2013556, 2017. https:\/\/doi.org\/10.3341\/kjo.2016.0118.","journal-title":"Korean J. Ophthalmol."}],"container-title":["Annals of Biomedical Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10439-023-03365-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10439-023-03365-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10439-023-03365-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T22:09:18Z","timestamp":1699481358000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10439-023-03365-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,19]]},"references-count":119,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["3365"],"URL":"https:\/\/doi.org\/10.1007\/s10439-023-03365-0","relation":{},"ISSN":["0090-6964","1573-9686"],"issn-type":[{"value":"0090-6964","type":"print"},{"value":"1573-9686","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,19]]},"assertion":[{"value":"13 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}